Spots Global Cancer Trial Database for anlotinib hydrochloride capsules
Every month we try and update this database with for anlotinib hydrochloride capsules cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer | NCT04924192 | Advanced Lung C... | TQB3616 capsule... Anlotinib Hydro... Irinotecan Hydr... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | NCT05145218 | Recurrent Plati... | Anlotinib Hydro... Paclitaxel inje... TQB2450 injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | NCT04964479 | Non Small Cell ... | TQB2450 injecti... Anlotinib Hydro... Pembrolizumab i... Placebo | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | NCT06010901 | Colorectal Canc... | TQB2618 injecti... Penpulimab inje... Anlotinib hydro... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | NCT05145218 | Recurrent Plati... | Anlotinib Hydro... Paclitaxel inje... TQB2450 injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy | NCT04507035 | Head and Neck C... | Anlotinib hydro... | 18 Years - 75 Years | Sun Yat-sen University | |
| A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | NCT05975645 | Advanced Hepato... | Penpulimab inje... TQB2618 injecti... Anlotinib Hydro... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy | NCT04507035 | Head and Neck C... | Anlotinib hydro... | 18 Years - 75 Years | Sun Yat-sen University | |
| A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma | NCT04827004 | Diffuse Large B... | Anlotinib Hydro... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) | NCT04344158 | Advanced Hepato... | AK105 Injection Anlotinib Hydro... Sorafenib Tosyl... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer | NCT04924192 | Advanced Lung C... | TQB3616 capsule... Anlotinib Hydro... Irinotecan Hydr... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) | NCT04344158 | Advanced Hepato... | AK105 Injection Anlotinib Hydro... Sorafenib Tosyl... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | NCT06010901 | Colorectal Canc... | TQB2618 injecti... Penpulimab inje... Anlotinib hydro... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma | NCT04827004 | Diffuse Large B... | Anlotinib Hydro... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Treatment of Advanced Intrahepatic Cholangiocarcinoma | NCT03940378 | ICC | Levamisole Hydr... Anlotinib Hydro... | 18 Years - 65 Years | The First Affiliated Hospital of Zhengzhou University | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | NCT04964479 | Non Small Cell ... | TQB2450 injecti... Anlotinib Hydro... Pembrolizumab i... Placebo | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma | NCT04827004 | Diffuse Large B... | Anlotinib Hydro... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
